| Patents for C12N 15 - Mutation or genetic engineering; Dna or rna concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor (402,210) |
|---|
| 06/17/1999 | CA2315216A1 Tgc method for inducting targeted somatic transgenesis |
| 06/17/1999 | CA2314434A1 Dna molecules encoding human nuclear receptor protein, nnr5 |
| 06/17/1999 | CA2314267A1 Anti-pathogen system and methods of use thereof |
| 06/17/1999 | CA2314225A1 Method for detecting apoptosis using fret labeled oligonucleotides |
| 06/17/1999 | CA2314006A1 Method and composition to enhance the efficacy of a vaccine using chemokines |
| 06/17/1999 | CA2314005A1 Methods for preparation of vaccines against cancer |
| 06/17/1999 | CA2313823A1 Porphorymonas gingivalis polypeptides and nucleotides |
| 06/17/1999 | CA2313806A1 Postweaning multisystemic wasting syndrome virus from pigs |
| 06/17/1999 | CA2313706A1 Method for producing transgenic plants with modified 5-aminolevulinic acid biosynthesis, method for identifying 5-aminolevulinic acid synthesis effectors |
| 06/17/1999 | CA2313705A1 Restin and methods of use thereof |
| 06/17/1999 | CA2313703A1 Vaccines containing attenuated bacteria |
| 06/17/1999 | CA2313654A1 Methods and reagents for preservation of dna in bodily fluids |
| 06/17/1999 | CA2313483A1 Assessment of human papilloma virus-related disease |
| 06/17/1999 | CA2313464A1 Mammalian alpha helical protein-1 |
| 06/17/1999 | CA2313451A1 Cyclic gmp phosphodiesterase |
| 06/17/1999 | CA2313450A1 G-protein coupled receptors associated with immune response |
| 06/17/1999 | CA2313447A1 Nucleotide sequences encoding the tomato light hypersensitive phenotype, encoded proteins and uses thereof |
| 06/17/1999 | CA2313446A1 Plant uridine diphosphate-glucose dehydrogenase genes, proteins, and uses thereof |
| 06/17/1999 | CA2313390A1 Peptide antagonists of vascular endothelial growth factor |
| 06/17/1999 | CA2313382A1 Control of flowering time and yield in plants by transformation with an invertase gene |
| 06/17/1999 | CA2313381A1 Bone morphogenetic protein (bmp)-17 and bmp-18 and compositions thereof |
| 06/17/1999 | CA2313350A1 A transcriptional coactivator that interacts with tat protein and regulates its binding to tar rna |
| 06/17/1999 | CA2313348A1 Soluble inhibitors of vascular endothelial growth factor and use thereof |
| 06/17/1999 | CA2313252A1 Method to identify transcriptional modulators |
| 06/17/1999 | CA2313251A1 Mutants of endostatin, "em 1" having anti-angiogenic activity and methods of use thereof |
| 06/17/1999 | CA2312945A1 Method for identifying nucleic acids by electro-spray mass spectrometry |
| 06/17/1999 | CA2312941A1 Peptide-based gemini compounds |
| 06/17/1999 | CA2312734A1 Vegetable gnti sequences and the use thereof to obtain plants with a reduced or lack of n-acetylglucosaminyltransferase i (gnti) activity |
| 06/17/1999 | CA2312698A1 Compositions and methods for treatment of hepatitis c virus-associated diseases |
| 06/17/1999 | CA2312697A1 Cadherin-like polypeptides, methods and compositions related thereto |
| 06/17/1999 | CA2312568A1 Self-addressable self-assembling microelectronic integrated systems, component devices, mechanisms, methods, and procedures for molecular biological analysis and diagnostics |
| 06/17/1999 | CA2312484A1 Hepatitis c virus ns5b truncated protein and methods thereof to identify antiviral compounds |
| 06/17/1999 | CA2312477A1 T-type voltage-gated calcium channels and method of using same |
| 06/17/1999 | CA2312476A1 Fibrinogen-converting enzyme hybrids |
| 06/17/1999 | CA2312291A1 Novel vectors and genes exhibiting increased expression |
| 06/17/1999 | CA2312289A1 Tumor antigen peptide derivatives |
| 06/17/1999 | CA2312287A1 Methods of producing anti-angiogenic proteins: endostatin, angiostatin or restin, using a pichia yeast expression system |
| 06/17/1999 | CA2312273A1 Cancer susceptibility mutations of brca1 |
| 06/17/1999 | CA2312052A1 Method for identifying nucleic acids by means of matrix-assisted laser desorption/ionisation mass spectrometry |
| 06/17/1999 | CA2312006A1 Nucleic acid mediated rna tagging and rna revision |
| 06/17/1999 | CA2311681A1 Human interferon-epsilon: a type i interferon |
| 06/17/1999 | CA2311645A1 Gene family with transformation modulating activity |
| 06/17/1999 | CA2311600A1 Method for purifying plasmid dna and plasmid dna substantially free of genomic dna |
| 06/17/1999 | CA2311333A1 Methods for making nucleic acids |
| 06/17/1999 | CA2311283A1 Purification and microsequencing of hyaluronidase isozymes |
| 06/17/1999 | CA2310782A1 Methods of nucleic acid isolation |
| 06/17/1999 | CA2310381A1 Method and cells to screen combinatorial libraries |
| 06/17/1999 | CA2255286A1 Galanin transgenic mice |
| 06/16/1999 | EP0923050A2 Scanned image alignment systems and methods |
| 06/16/1999 | EP0922957A1 Method to determine biomeolecular interaction |
| 06/16/1999 | EP0922771A2 Method for the detection of large concentrations of a virus in blood plasma and/ or blood serum using the polymerase chain reaction |
| 06/16/1999 | EP0922768A2 Oncogene or virus-driven expression systems |
| 06/16/1999 | EP0922767A1 Ribozymes capable of conferring resistance to potyvirus infection, and plants expressing said ribozymes |
| 06/16/1999 | EP0922766A1 Process for the inactivation of genes which code for enzymes for the catabolism of phenyl acetate, plasmids involved in such process and strains transformed therewith |
| 06/16/1999 | EP0922765A1 Modified DNA-polymerase from carboxydothermus hydrogenoformans and its use for coupled reverse transcription and polymerase chain reaction |
| 06/16/1999 | EP0922764A1 Soybean ADP ribosylation factor |
| 06/16/1999 | EP0922763A1 Inwardly rectifying potassium channel gene and protein |
| 06/16/1999 | EP0922762A1 Drug binding protein |
| 06/16/1999 | EP0922760A2 Transgenic animal not expressing endogenous osteoclastogenesis inhibitory factor (OCIF) |
| 06/16/1999 | EP0922226A1 Process for determining the status of an organism by peptide measurement |
| 06/16/1999 | EP0922223A1 A method for diagnosis and prognosis of cancer |
| 06/16/1999 | EP0922217A1 Micro injector sample delivery system for charged molecules |
| 06/16/1999 | EP0922114A2 Catalytic nucleic acid and its medical use |
| 06/16/1999 | EP0922113A1 Sequential hybridization of fungal cell dna and method for the detection of fungal cells in clinical material |
| 06/16/1999 | EP0922112A1 Formazan-based immunoassay |
| 06/16/1999 | EP0922111A1 Induction of t cell tolerance using a soluble molecule that can simultaneously block two costimulatory pathways |
| 06/16/1999 | EP0922110A2 Spatial and temporal control of gene expression using a heat shock protein promoter in combination with local heat |
| 06/16/1999 | EP0922109A1 Novel yeast promoters suitable for expression cloning in yeast and heterologous expression of proteins in yeast |
| 06/16/1999 | EP0922108A1 Novel expression vectors |
| 06/16/1999 | EP0922107A1 Human kallikrein |
| 06/16/1999 | EP0922106A1 Biosensors |
| 06/16/1999 | EP0922105A2 Infectious papillomavirus pseudoviral particles |
| 06/16/1999 | EP0922104A1 Gene expression in plants |
| 06/16/1999 | EP0922103A1 NEW $i(BRUCELLA) ANTIGENS, RECOMBINANT POLYPEPTIDES, NUCLEIC ACIDS CODING FOR THE SAME AND USE THEREOF IN DIAGNOSTIC AND PROPHYLACTIC METHODS AND KITS |
| 06/16/1999 | EP0922102A1 Hepatocyte growth factor receptor agonists and uses thereof |
| 06/16/1999 | EP0922101A1 Egf-like factor from chromaffin granules and glia cell-derived neurotrophic factor with survival-promoting activity on daergic neurons |
| 06/16/1999 | EP0922100A2 Secreted proteins and polynucleotides encoding them |
| 06/16/1999 | EP0922099A1 Fas ligand-like protein, its production and use |
| 06/16/1999 | EP0922098A1 Sexing gene |
| 06/16/1999 | EP0922097A1 Single-step excision means |
| 06/16/1999 | EP0922096A1 Transgenic plants resistant to geminivirus infection |
| 06/16/1999 | EP0922095A1 Compositions and methods for production of male-sterile plants |
| 06/16/1999 | EP0922094A2 Gene encoding oxalate decarboxylase from aspergillus phoenices |
| 06/16/1999 | EP0922059A1 Monoclonal antibodies that define unique meningococcal b epitopes and their use in the preparation of vaccine compositions |
| 06/16/1999 | EP0922056A1 New fibrinogen binding protein originating from coagulase-negative staphylococcus |
| 06/16/1999 | EP0922053A1 MAMMALIAN ADDITIONAL SEX COMBS (MAMMALIAN Asx) ACTS AS A TUMOR SUPPRESSOR |
| 06/16/1999 | EP0922052A1 Rat ob receptors and nucleotides encoding them |
| 06/16/1999 | EP0921821A1 2-methoxyestradiol-induced apoptosis in cancer cells |
| 06/16/1999 | EP0921820A1 Gene therapy for obesity |
| 06/16/1999 | EP0921818A1 Therapeutic and diagnostic methods and compositions based on jagged/notch proteins and nucleic acids |
| 06/16/1999 | EP0921816A1 Opsonin-enhanced cells, and methods of modulating an immune response to an antigen |
| 06/16/1999 | EP0921815A1 Therapeutic uses of humanized antibodies against alpha-4 integrin |
| 06/16/1999 | EP0921814A1 Method for increasing viability and transformation efficiency of bacteria during storage at low temperatures |
| 06/16/1999 | EP0921719A1 Genes enhancing disease resistance in plants |
| 06/16/1999 | EP0674715B1 Methods for stable transformation of wheat |
| 06/16/1999 | EP0670900B1 Bacillus thuringiensis isolates active against lepidopteran pests |
| 06/16/1999 | EP0669976B1 Screening method using transcription factor DP-1 |
| 06/16/1999 | CN1219974A Recombinant nucleic acid sequences and methods for determining both genotoxicity and mutagenicing of sample and kinetics of genetoxicity |
| 06/16/1999 | CN1219972A Multiplex amplification of short tandem repeat loci |
| 06/16/1999 | CN1219971A Morphological mutants of filamentous fungi |